BPC 157 Benefits and Research Applications BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or A new pilot study administered BPC 157 intravenously at doses 2040 higher than what's typically used in biohacking circles 10 mg on day one and 20 mg on day two. To put